Revision of Deep Brain Stimulator in Patients With Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

July 5, 2026

Study Completion Date

July 20, 2026

Conditions
Pain ManagementRegional AnesthesiaDeep Brain StimulationParkinsons Disease
Interventions
PROCEDURE

Patients who underwent surgery under general anesthesia

Patients undergoing surgery under general anesthesia will undergo general anesthesia induction. During the skin closure, patients received 50 mg of dexketoprofen. Additionally, a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered intravenously for multimodal analgesia.

PROCEDURE

Patients who underwent surgery under regional anesthesia

"25 cc (15 cc 0.5% bupivacaine + 5 cc 2% lidocaine + 5 cc isotonic) local anesthetic solution is prepared. 10 cc of the medication is administered into the interpectoral plane, and 15 cc into the pectoserratus plane.~During the skin closure, patients received 50 mg of dexketoprofen. Additionally, a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered intravenously for multimodal analgesia."

Trial Locations (1)

06170

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT07176494 - Revision of Deep Brain Stimulator in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter